🔴 Hims & Hers Health is trading 10.5% down today after mixed FDA vote on peptide products

Hims & Hers Health is trading 10.5% down today at €22.48 as the stock continues to react to recent U.S. FDA scrutiny of its peptide products.

• Shares are extending a pullback triggered by a mixed FDA Pharmacy Compounding Advisory Committee vote regarding seven peptides central to the company's growth strategy.
• The regulatory developments keep future product availability and potential growth constraints in focus for investors.